跳至主要内容
临床试验/ACTRN12618001193268
ACTRN12618001193268已完成未知

A randomised, controlled trial of the RECOVER tailored psychological intervention for improving global functioning in early stage bipolar disorder

Orygen0 个研究点目标入组 67 人开始时间: 2018年7月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
67

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
15 Years 至 25 Years(—)
性别
All

入选标准

  • Diagnosis of BD-I: As per Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5; 31);
  • - Early stage BD: Stage 2 and early illness phases of Stage 3 disorder. At least one manic episode in the previous 2 years, no more than 5 manic or hypomanic episodes over lifetime.
  • - Length of treatment duration: within the first 6 months of treatment at a SEI service
  • - Capacity: To consent to the study and comply with study procedures.

排除标准

  • -Schizophrenia spectrum disorder
  • -Manic symptoms purely related to periods of peak drug intoxication
  • -Involvement in another interventional trial, unless discussed and agreed by Investigators, CI and Sponsor to be allowed, on a case-by-case basis
  • -Presence of developmental disability, and full scale intelligence quotient <70 that would compromise the person’s ability to understand cognitive and behavioural aspects of the intervention
  • -An inability to speak English without an interpreter

研究者

发起方
Orygen

相似试验